Financials
- Market Capitalization 227.76 M
- Employee 228
- Founded 2008
- CEO N/A
- Website www.karyopharm.com
- Headquarter Delaware, United States
- FIGI BBG001J272L7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3528 | IVVD Invivyd, Inc. - Common Stock | 0.79 USD | +1.28% | -7.06% | -2.47% | +9.72% | 232.74 M USD | ||
| 3542 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 3.82 USD | -4.26% | -7.28% | -7.28% | +25.66% | 228.74 M USD | ||
| 3551 | CHRS Coherus Oncology, Inc. - Common Stock | 1.47 USD | -4.55% | -13.02% | +2.80% | -8.70% | 226.75 M USD | ||
| 3552 | NAUT Nautilus Biotechnology, Inc. - Common Stock | 1.78 USD | -5.82% | +4.09% | -22.27% | +131.17% | 226.20 M USD |
Frequently asked questions about Karyopharm Therapeutics Inc. - Common Stock
What is the Karyopharm Therapeutics Inc. - Common Stock stock price today?
The current price of Karyopharm Therapeutics Inc. - Common Stock (KPTI) is 10.05. Over the past 24 hours, the stock has changed by -2.80%. Follow the KPTI chart for real-time price dynamics.
What is the stock ticker of Karyopharm Therapeutics Inc. - Common Stock?
Karyopharm Therapeutics Inc. - Common Stock trades under the ticker KPTI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Karyopharm Therapeutics Inc. - Common Stock stock going up?
KPTI has changed by +4.91% over the last week, +4.15% over the last month, and +4.25% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Karyopharm Therapeutics Inc. - Common Stock net income for the last quarter?
Karyopharm Therapeutics Inc. - Common Stock reported net income of -22.39 M for the last quarter. The previous quarter showed -102.2 M, which means net income changed by +78.09%.
How many employees does Karyopharm Therapeutics Inc. - Common Stock have?
As of the latest available data, Karyopharm Therapeutics Inc. - Common Stock has 228 employees. Workforce size can provide additional context about the company's scale and operations.
What is Karyopharm Therapeutics Inc. - Common Stock EBITDA?
Karyopharm Therapeutics Inc. - Common Stock EBITDA is -31.3 M, and its EBITDA margin is -111.15%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Karyopharm Therapeutics Inc. - Common Stock stock?
You can buy Karyopharm Therapeutics Inc. - Common Stock (KPTI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Karyopharm Therapeutics Inc. - Common Stock stock?
Investing in Karyopharm Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KPTI chart and related analysis on metatrader.com as part of your research.